Development
Dolby Laboratories, Inc.
DLB
$71.98
-$0.36-0.50%
NYSE
12/29/2023 | 09/29/2023 | 06/30/2023 | 03/31/2023 | 12/30/2022 | |
---|---|---|---|---|---|
Revenue | 3.50% | 3.66% | 2.12% | 1.65% | -0.48% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 3.50% | 3.66% | 2.12% | 1.65% | -0.48% |
Cost of Revenue | 4.94% | 7.93% | 14.32% | 13.84% | 12.30% |
Gross Profit | 3.31% | 3.12% | 0.66% | 0.24% | -1.94% |
SG&A Expenses | 0.21% | -2.86% | -5.87% | -6.44% | 5.12% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 2.52% | 0.33% | -1.56% | -2.50% | 4.50% |
Operating Income | 8.01% | 19.59% | 19.05% | 19.73% | -18.39% |
Income Before Tax | 3.17% | 16.15% | 19.63% | 25.55% | -19.78% |
Income Tax Expenses | 1.59% | 54.26% | 94.47% | 152.53% | 69.75% |
Earnings from Continuing Operations | 3.51% | 9.65% | 9.55% | 12.72% | -28.14% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -1,452.68% | -622.75% | -273.55% | -220.52% | 212.00% |
Net Income | 2.62% | 9.00% | 9.33% | 12.47% | -28.07% |
EBIT | 8.01% | 19.59% | 19.05% | 19.73% | -18.39% |
EBITDA | 4.86% | 11.99% | 9.03% | 10.66% | -17.08% |
EPS Basic | 5.21% | 14.18% | 15.08% | 17.81% | -25.67% |
Normalized Basic EPS | 21.30% | 34.19% | 32.65% | 31.02% | -13.80% |
EPS Diluted | 4.22% | 14.31% | 15.55% | 18.90% | -24.34% |
Normalized Diluted EPS | 20.62% | 34.57% | 33.51% | 32.57% | -12.38% |
Average Basic Shares Outstanding | -3.04% | -4.20% | -4.84% | -3.98% | -2.65% |
Average Diluted Shares Outstanding | -2.46% | -4.17% | -5.36% | -5.11% | -4.24% |
Dividend Per Share | 9.62% | 8.82% | 8.00% | 9.28% | 10.64% |
Payout Ratio | 0.03% | -0.05% | -0.05% | -0.06% | 0.52% |